Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‐matched analysis. The gene discussed is SLC5A2; the disease is acute coronary syndrome.